… , whereas p53, a regulatory protein which arrests the cell cycle in the G0 phase to repair DNA
damage, is down-regulated in the same areas of cartilage (unpublished data by Iannone F. …

OBJECTIVE: To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF
therapy on the basis of the data included in the GISEA register. METHODS: The study …

Since the introduction of biologics for the treatment of rheumatoid arthritis (RA), psoriatic arthritis
(PsA), ankylosing spondylitis (AS), and psoriasis (Pso) an increased risk of tuberculosis (…

… New York Heart Association (D), the patient's age at the onset of Raynaud's phenomenon
(E), the diffusing capacity of the lung for carbon monoxide (DLCO) in percentage of normal (F) …

Objectives To determine the causes of death and risk factors in systemic sclerosis (SSc).
Methods Between 2000 and 2011, we examined the death certificates of all French patients …

Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

… E and F, Variation in the forced expiratory volume in 1 second (FEV 1 ) (E) and eosinophil
count (F). Values in A, B, E, and F are the median and interquartile range.* = P < 0.05; ** = P < …

Objective. We aimed to investigate the expression of nerve growth factor (NGF) and high
affinity NGF receptor (p140 TrkA) on chondrocytes from human healthy and osteoarthritic …

Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an
autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and interstitial …

Objective To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical
practice. Methods We performed a prospective study including patients with SSc from the …